Statistics, data science, health data science, biostatistics, gastrointestinal cancer

“Management Data Analysis I ・ II”, “Cultural Statistics”, “Specialized Exercise I ・ II”, “Academic Literacy PC” (faculties)
"Measurement and Quantitative Methodology" (Graduate School)
“Biostatistics”, “Introduction to Clinical Research”, “Statistical Social Survey Method”, “Experience on Statistical Social Survey Method”, “DS Project”, “Graduation Research”, “Nursing Informatics” (planned)

Graduated from the Faculty of Culture and Information Studies, Doshisha University in 2011
2018 Completed a Master's degree in Statistics at the University of Western Michigan, United States in 2018
2018 Completed the Graduate Certificate in Biostatistics (Biostatistics) course at the University of Western Michigan, United States.
Graduated from Yamaguchi University Graduate School of Medicine in 2023.

Ph.D. (Medical)
Master of Science (Statistics)
Graduate Certificate (Biostatistics)

International Association of Econometric Biology, Japan Society of Meterology, Japan Society of Gastroenterology, Japan Society of Cancer Therapy, American Institute of Statistical Science, Japan Society of Cancer, Life Intelligence Consortium (LINC)

Statistical consulting in the fields of statistics, data science, health data science, biostatistics, natural and humanities and social sciences, R, personalized treatment, bridging studies, clinical trials, gastrointestinal cancer, cancer immunity, dimensional shrinkage, classification, SAS, Python, Julia

　I have been conducting research that leads to bridging research and personalized treatment, focusing on statistical and data science methods, especially on the application of gastrointestinal cancer research and statistical consulting of medical research, including clinical trials. Taking advantage of our experience and network in joint research with medical, research institutes, IT/pharmaceutical companies, etc., we promote research toward the theory culture.
　In addition, we participate in the Life Intelligence Consortium (LINC)* and conduct research activities by industry, academia and government as a representative and sharer of joint research such as "building a digital health data infrastructure nationwide", "individualization of medication/nutrition guidance", "cost-effective analysis of treatment using natural language processing", and "efficiency of clinical trials".
*The All Japan Consortium was established in November 2016 by Kyoto University, RIKEN, Pharmaceutical Infrastructure, Health and Nutrition Research Institute, etc., with the aim of developing AI and big data in the life sciences related to pharmaceutical, chemical, food, medical, and healthcare.

・High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancer. Kei Furuya, Masao Nakajima, Ryouichi Tsunedomi, Yuki Nakagami, Ming Xu, et al. BMC cancer. 2024.
・Clinical outcomes of second‑line chemotherapy after gemcitabine and cisplatin plus S‑1 treatment for patients with advanced biliary tract cancer in the KHBO1401‑3A study. Yoshitaro Shindo, Hiroaki Nagano, Yuki Nakagami, et al. ONCOLOGY REPORTS. 2023.
・CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule. Yuki Nakagami, Shoichi Hazama, Nobuaki Suzuki, et al. BMC Cancer. 2022.
・Association of Plasma Branched-Chain and Aromatic Amino Acids with Reduction in Kidney Function Evaluated in Apparently Healthy Adults. MH Mahbub, Natsu Yamaguchi, Yuki Nakagami, et al. Journal of Clinical Medicine. 2021.
・Viral elimination is essential for improving surgical outcomes of HCV-related HCC: Multicenter retrospective analysis. Masao Nakajima, Shogo Kobayashi, Yuki Nakagami, et al. Annals of Gastroenterological Surgery. 2020. A top cited paper in Annals of Gastroenterological Surgery 2020-2021.
・Intratumoral-infiltrating CD4+ and FOXP3+ T Cells as Strong Positive Predictive Markers for the Prognosis of Resectable Colorectal Cancer. Taichi Kuwahara, Shoichi Hazama, Yuki Nakagami, et al. British Journal of Cancer. 2019.
・In 2020, the 33rd Japan Society of Biotherapy Encouragement Award Excellence Award
・In 2020, the 41st Cancer Immunology Study Group Encouragement Award
・In 2019, the 57th Annual Meeting of the Japan Society of Cancer Therapy

・Scientist Grants for Scientific Research (C) “Infiltration of colon tumors by CyTOF CD4+FOXP3+ cells and their role as prognostic factors” Research sharing
・Research Representative: "Identification of Stage II colon cancer prognostic factors by CyTOF analysis of tumor infiltration immune cells," a research project by young researchers at Yamaguchi University Fund.
・Fundamental Research C: "Development of early diagnostic methods for non-viral liver cancer with natural immunological factors as new biomarkers" Research sharing
・Grants for Scientific Research (C) "Development of early diagnosis markers for liver cancer associated with lifestyle-related diseases: Analysis of extracellular vesicles" Research sharing
・Grant-in-Aid for Scientific Research (C) "Development of a multi-month life prediction system for cancer based on in-hospital real-world data" Research Representative
・Grant-in-Aid for Scientific Research (C) "Development of AI to predict pathological progression using real-world data using electronic medical record information" Research sharing
・Japan Science and Technology Agency (COI-NEXT) "well-being community co-creation base created by a model of economic development based on health and an approach to all generations" Research sharing:

Member of the University League Yamaguchi Data Science Education Working Group
On-site lectures Okayama Yoshiizumi High School, Shimo-Kansai High School (Super Science High School Certified School), Hagi High School, Kitakyusyu High School
Japan Hepatobiliary Pancreatic Oncology Network (JON-HBP) Statistical Advisor
Kansai Livelihood On Cologie Group (KHBO) Statistical Advisor
Statistical advisor, National Hospital Organization Kanmon Medical Center
Assistant Professor, Graduate School of Medicine, Yamaguchi University
Department of Gastroenterology and Oncology, Graduate School of Medicine, Yamaguchi University
Department of Public Health and Preventive Medicine, Graduate School of Medicine, Yamaguchi University

Understanding phenomena, solving problems, and creating value through the approach of data science (data science)

・We value the colleagues in the laboratory.
・You can clearly explain your research topic and your research plan in your own words.
・You can engage in research independently.
・You can understand and evaluate other people's research.
・Develop the ability to explain in an easy-to-understand manner to non-specialists in the field.
・Students acquire the ability from finding and solving problems from the perspective of data science.
While valuing importance, everyone is working hard toward empirical graduation research on understanding phenomena, solving problems, and creating value through data design (planning), collection, and analysis using the approach of data science (data science).
We will provide guidance on "human resource development who can think of research from a statistical and data science perspective", "basic research on statistical and data science methods", and "application research that can be utilized in the fields of natural and humanities and social sciences".

<FY2023 Graduation Research> (Department of Economics)
Impact of emission regulations on the second-hand motorcycle market and future prospects
Investment Environment Outlook Using Text Mining - Analysis of the Relationship between Reporting and Stock Prices
Current status and future prospects of cashless payments
Possibilities of labgrown diamonds in the Japanese jewelry industry
Consideration of the relevance of logistics functions and Minato town development
Future prospects from an analysis of the current state of smart houses and management strategies
Consideration on the development of the OTT Platform in Korea -Focusing on the OTT Platform in Korea

[email protected]